90 results
Page 2 of 5
8-K
bn98u
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:40pm
8-K
EX-1.1
w97vq4
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
s5621badyh3z3rgbk4
21 Jul 23
Prospectus supplement with pricing info
3:37pm
DEF 14C
jcb2nbfkav93v8ax
17 May 23
Information statement
9:07am